{"name":"EssilorLuxottica","slug":"essilor","ticker":"EL","exchange":"Euronext Paris","domain":"essilorluxottica.com","description":"EssilorLuxottica SA is a Franco-Italian vertically integrated multinational holding company registered in Charenton-Le-Pont and headquartered in nearby Paris. It designs, produces and markets ophthalmic lenses, equipment and instruments, prescription glasses and sunglasses. It was founded on 1 October 2018 and its name is an amalgamation of the two major corporations which merged to create it; the French Essilor and the Italian Luxottica. The two companies have, since the merger, been restructured as subsidiaries of the new entity.","hq":"Charenton-le-Pont, France","founded":0,"employees":"40470","ceo":"Francesco Milleri","sector":"Vision Care / Ophthalmic Lenses / Eyewear","stockPrice":81.43,"stockChange":-0.7,"stockChangePercent":-0.85,"marketCap":"$29.5B","metrics":{"revenue":14833000448,"revenueGrowth":4.6,"grossMargin":74.7,"rdSpend":157900000,"netIncome":684000000,"cash":2181000000,"dividendYield":1.7,"peRatio":25.6,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2025-06-01","label":"Varilux patent cliff ($1.5B at risk)","drug":"Varilux","type":"patent_expiry","sentiment":"negative"},{"date":"2028-06-01","label":"Crizal patent cliff ($2.2B at risk)","drug":"Crizal","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2023-02-16","type":"earnings","headline":"EssilorLuxottica Reports Strong Q4 2022 Results","summary":"The company reported revenue of €8.4 billion and adjusted net income of €1.3 billion for the quarter.","drugName":"","sentiment":"positive"},{"date":"2022-09-01","type":"deal","headline":"EssilorLuxottica Acquires GrandVision","summary":"The company acquired GrandVision, a leading global optical retailer, for €7.1 billion.","drugName":"","sentiment":"positive"},{"date":"2022-05-12","type":"regulatory","headline":"EssilorLuxottica Receives FDA Approval for Varilux X Series","summary":"The company received FDA approval for its Varilux X Series lenses, which provide advanced visual comfort and clarity.","drugName":"","sentiment":"positive"}],"realNews":[{"date":"2026-03-24","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOandtdFJCUUZaZF9rZUxVd2k2SGlqZmZvZmgzVW9pV1RnYjRST3VwaWNKb1lTNVJOeW5SWmlvN1MwRGVPTDNGQmJoTkI5b0dIeE9vdlc4QS10YVpBcmswdWhxNVd6Xy1PcnF6dUhTdm9WS2ZFUDI2ZmlFUVpoVDcwYUtyMlRGTzB1YlE5c0laNmxzUQ?oc=5","date":"2025-07-09","type":"pipeline","source":"Yahoo Finance","summary":"ProKidney, Meta & EssilorLuxottica, Apple COO: Trending Tickers - Yahoo Finance","headline":"ProKidney, Meta & EssilorLuxottica, Apple COO: Trending Tickers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOT0U4SzNudl8wVkt2dHVoVGphZG0yRS1pQWhrTG9Jb2ZjS01MdnVmTGNMemNvdEpxZGdPNk80MGRlTjFiOXUyRXJJYXFMY3VsdUhlczFjdU4wMHVwbzZNTldqYkJ2Q0ctUHdTSGxyU1AwSk5saTdMTUdSVUVIVkJ0LUdadU5Kc0tNYk5FVVpicTd6Zw?oc=5","date":"2023-01-10","type":"pipeline","source":"Morningstar Canada","summary":"Vive La France? Stocks Off to a Flier in 2023 - Morningstar Canada","headline":"Vive La France? Stocks Off to a Flier in 2023","sentiment":"neutral"}],"patents":[{"drugName":"Varilux","drugSlug":"varilux","patentNumber":"","type":"Patent Cliff","expiryDate":"2025-06-01","territory":"US","annualRevenue":1500000000},{"drugName":"Crizal","drugSlug":"crizal","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":2200000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Johnson & Johnson","Alcon","Hoya"],"therapeuticFocus":["Vision Care","Ophthalmic Lenses"],"financials":{"source":"sec_edgar+yahoo","revenue":14326000000,"revenuePeriod":"2025-06-30","revenueHistory":[{"value":14326000000,"period":"2025-06-30"},{"value":15608000000,"period":"2024-06-30"},{"value":15910000000,"period":"2023-06-30"},{"value":17737000000,"period":"2022-06-30"},{"value":16215000000,"period":"2021-06-30"},{"value":14294000000,"period":"2020-06-30"}],"grossProfit":10597000000,"grossProfitHistory":[{"period":"2025-06-30","value":10597000000},{"period":"2024-06-30","value":11184000000},{"period":"2023-06-30","value":11346000000},{"period":"2022-06-30","value":13432000000}],"rdSpend":157900000,"rdSpendHistory":[],"sgaSpend":9456000000,"operatingIncome":1141000000,"operatingIncomeHistory":[{"period":"2025-06-30","value":1141000000},{"period":"2024-06-30","value":1563000000},{"period":"2023-06-30","value":1771000000},{"period":"2022-06-30","value":3544000000}],"netIncome":684000000,"netIncomeHistory":[{"period":"2025-06-30","value":-1133000000},{"period":"2024-06-30","value":390000000},{"period":"2023-06-30","value":1006000000},{"period":"2022-06-30","value":2390000000}],"eps":-3.15,"epsHistory":[{"period":"2025-06-30","value":-3.15},{"period":"2024-06-30","value":1.08},{"period":"2023-06-30","value":2.79},{"period":"2022-06-30","value":6.55}],"cash":2181000000,"cashHistory":[{"period":"2025-06-30","value":2921000000},{"period":"2024-06-30","value":3395000000},{"period":"2023-06-30","value":4029000000},{"period":"2022-06-30","value":3957000000}],"totalAssets":19892000000,"totalLiabilities":16027000000,"totalDebt":9467000000,"equity":3865000000,"operatingCashflow":1272000000,"operatingCashflowHistory":[{"period":"2025-06-30","value":1272000000},{"period":"2024-06-30","value":2360000000},{"period":"2023-06-30","value":1731000000},{"period":"2022-06-30","value":3040000000}],"capex":-602000000,"capexHistory":[{"period":"2025-06-30","value":-602000000},{"period":"2024-06-30","value":-919000000},{"period":"2023-06-30","value":-3289000000},{"period":"2022-06-30","value":-1040000000}],"freeCashflow":670000000,"dividendsPaid":-618000000,"buybacks":-35000000,"employees":40470,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":2279000000,"ebit":261000000,"ebitda":462000000,"period":"2026-03-31","revenue":3712000000,"epsBasic":0.25,"netIncome":89000000,"rdExpense":null,"epsDiluted":0.24,"grossProfit":2836000000,"operatingIncome":557000000},{"sga":2627000000,"ebit":418000000,"ebitda":615000000,"period":"2025-12-31","revenue":4229000000,"epsBasic":0.45,"netIncome":162000000,"rdExpense":null,"epsDiluted":0.44,"grossProfit":3235000000,"operatingIncome":608000000},{"sga":2296000000,"ebit":195000000,"ebitda":395000000,"period":"2025-09-30","revenue":3481000000,"epsBasic":0.13,"netIncome":47000000,"rdExpense":null,"epsDiluted":0.13,"grossProfit":2554000000,"operatingIncome":258000000},{"sga":2315000000,"ebit":-363000000,"ebitda":-153000000,"period":"2025-06-30","revenue":3411000000,"epsBasic":-1.51,"netIncome":-546000000,"rdExpense":null,"epsDiluted":-1.51,"grossProfit":2456000000,"operatingIncome":141000000},{"sga":2258000000,"ebit":328000000,"ebitda":532000000,"period":"2025-03-31","revenue":3550000000,"epsBasic":0.44,"netIncome":159000000,"rdExpense":null,"epsDiluted":0.44,"grossProfit":2661000000,"operatingIncome":403000000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-12-31","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":81.43,"previousClose":82.13,"fiftyTwoWeekHigh":121.64,"fiftyTwoWeekLow":62.03,"fiftyTwoWeekRange":"62.03 - 121.64","fiftyDayAverage":79.87,"twoHundredDayAverage":93.94,"beta":1.21,"enterpriseValue":35888218112,"forwardPE":25.6,"priceToBook":7.31,"priceToSales":1.99,"enterpriseToRevenue":2.42,"enterpriseToEbitda":15.27,"pegRatio":1.42,"ebitda":2350000128,"ebitdaMargin":15.8,"freeCashflow":1807624960,"operatingCashflow":1798000000,"totalDebt":9299999744,"debtToEquity":232.9,"currentRatio":1.27,"returnOnAssets":4.9,"returnOnEquity":-5.9,"analystRating":"2.4 - Buy","recommendationKey":"buy","numberOfAnalysts":22,"targetMeanPrice":94.64,"targetHighPrice":125,"targetLowPrice":70,"dividendRate":1.4,"payoutRatio":4.71,"fiveYearAvgDividendYield":1.61,"exDividendDate":1780012800,"insiderHeldPercent":1.6,"institutionHeldPercent":95.7,"sharesOutstanding":247287571,"floatShares":246281035,"sharesShort":7710136,"shortRatio":1.83,"shortPercentOfFloat":2.1,"epsTrailing":-0.7,"epsForward":3.18,"revenuePerShare":41.01,"bookValue":11.15,"officers":[{"age":51,"name":"Mr. Stephane  de la Faverie","title":"CEO, President & Director"},{"age":51,"name":"Mr. Akhil  Shrivastava","title":"Executive VP & CFO"},{"age":50,"name":"Ms. Rashida K. La Lande","title":"Executive VP & General Counsel"},{"age":64,"name":"Ms. Jane Hertzmark Hudis","title":"Executive VP & Chief Brand Officer"},{"age":60,"name":"Mr. Brian J. Franz","title":"Chief Technology, Data & Analytics Officer"},{"age":null,"name":"Ms. Deborah  Krulewitch","title":"Senior Vice President of Corporate Administration"},{"age":55,"name":"Ms. Laraine A. Mancini","title":"Senior Vice President Finance & Strategy & Head of Investor Relations"},{"age":49,"name":"Ms. Meridith  Webster","title":"Chief Communications and Public Affairs Officer"}],"industry":"Household & Personal Products","irWebsite":"http://investors.elcompanies.com/phoenix.zhtml?c=109458&p=irol-irhome","website":"https://www.elcompanies.com","phone":"212 572 4200"}}